These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1466949)
21. AIDS 1995. Vaccines and immunology: overview. Montelaro RC; Wigzell H AIDS; 1995; 9 Suppl A():S111-2. PubMed ID: 8819577 [No Abstract] [Full Text] [Related]
22. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine. Bhardwaj N; Walker BD Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710 [No Abstract] [Full Text] [Related]
23. Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus. Ensoli B; Cafaro A AIDS Clin Rev; 2000-2001; ():23-61. PubMed ID: 10999215 [No Abstract] [Full Text] [Related]
24. Predictive value of primate models for AIDS. Haigwood NL AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617 [TBL] [Abstract][Full Text] [Related]
25. Cytotoxic T-cell recognition of HIV proteins and peptides. Nixon DF; McMichael AJ AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319 [No Abstract] [Full Text] [Related]
26. Fifty volunteer for live-vaccine trial. James JS AIDS Treat News; 1997 Oct; (No 280):1-2. PubMed ID: 11364735 [TBL] [Abstract][Full Text] [Related]
27. Fc receptor but not complement binding is important in antibody protection against HIV. Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298 [TBL] [Abstract][Full Text] [Related]
28. Current prospects for the development of a therapeutic vaccine for the treatment of HIV type 1 infection. Egan MA AIDS Res Hum Retroviruses; 2004 Aug; 20(8):794-806. PubMed ID: 15320982 [No Abstract] [Full Text] [Related]
29. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor. Cohen J Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780 [No Abstract] [Full Text] [Related]
30. AIDS vaccine: new ideas from old approaches. Beale AJ J R Soc Med; 2003 Jul; 96(7):347-8. PubMed ID: 12835449 [No Abstract] [Full Text] [Related]
34. Vaccines against human immunodeficiency virus--progress and prospects. Letvin NL N Engl J Med; 1993 Nov; 329(19):1400-5. PubMed ID: 8413438 [No Abstract] [Full Text] [Related]
35. Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. World Health Organization Working Group. AIDS Res Hum Retroviruses; 1994 Feb; 10(2):221-2. PubMed ID: 8198875 [No Abstract] [Full Text] [Related]
36. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles. Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793 [TBL] [Abstract][Full Text] [Related]
37. Challenges and opportunities for development of an AIDS vaccine. Nabel GJ Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631 [TBL] [Abstract][Full Text] [Related]
38. Mucosal immunity, HIV transmission, and AIDS. Miller CJ; McGhee JR; Gardner MB Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249 [No Abstract] [Full Text] [Related]
39. Is an HIV vaccine possible? McMichael AJ; Hanke T Nat Med; 1999 Jun; 5(6):612-4. PubMed ID: 10371492 [No Abstract] [Full Text] [Related]
40. India, Japan launch HIV vaccines to match local strains. Chou IH; Jayaraman KS Nat Med; 2004 Mar; 10(3):215. PubMed ID: 14991027 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]